Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266526
Status:
COMPLETED
Last Update Posted:
2013-03-04
First Post:
2005-12-16
Brief Title:
Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV
Sponsor:
Allergopharma GmbH Co KG
Organization:
Allergopharma GmbH Co KG
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2004-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-16
First Submit QC Date:
December 16 2005
Study First Post Date:
2005-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-01
Last Update Post Date:
2013-03-04
Last Update Post Date Type:
ESTIMATED